Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer

Detalhes bibliográficos
Autor(a) principal: Silva, Natália Cristina Gomes da
Data de Publicação: 2022
Outros Autores: Viveiros, Diana Dalzy, Almeida, Carlos Eduardo Bonacossa de, Arissawa, Marcia, Missailidis, Sotiris
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/52282
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_266d91df77bec99d8011d84cb304d012
oai_identifier_str oai:www.arca.fiocruz.br:icict/52282
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Silva, Natália Cristina Gomes daViveiros, Diana DalzyAlmeida, Carlos Eduardo Bonacossa deArissawa, MarciaMissailidis, Sotiris2022-04-14T17:39:54Z2022-04-14T17:39:54Z2022SILVA, N. C. G. et al. Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 51.https://www.arca.fiocruz.br/handle/icict/5228210.35259/isi.2022_52282Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Instituto de Radioproteção e Dosimetria. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosAptâmerosCâncer de mamaTerapia e diagnósticoAptamerBreast cancerTherapy and diagnosisNeoplasias da MamaDiagnósticoDevelopment of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancerinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/52282/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALAnais6thISI2022_51.pdfAnais6thISI2022_51.pdfapplication/pdf142769https://www.arca.fiocruz.br/bitstream/icict/52282/2/Anais6thISI2022_51.pdfcfdefb1776468aefe9ccbc6b24234a4eMD52icict/522822023-04-26 16:56:09.407oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:56:09Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
title Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
spellingShingle Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
Silva, Natália Cristina Gomes da
Aptâmeros
Câncer de mama
Terapia e diagnóstico
Aptamer
Breast cancer
Therapy and diagnosis
Neoplasias da Mama
Diagnóstico
title_short Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
title_full Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
title_fullStr Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
title_full_unstemmed Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
title_sort Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer
author Silva, Natália Cristina Gomes da
author_facet Silva, Natália Cristina Gomes da
Viveiros, Diana Dalzy
Almeida, Carlos Eduardo Bonacossa de
Arissawa, Marcia
Missailidis, Sotiris
author_role author
author2 Viveiros, Diana Dalzy
Almeida, Carlos Eduardo Bonacossa de
Arissawa, Marcia
Missailidis, Sotiris
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Silva, Natália Cristina Gomes da
Viveiros, Diana Dalzy
Almeida, Carlos Eduardo Bonacossa de
Arissawa, Marcia
Missailidis, Sotiris
dc.subject.other.pt_BR.fl_str_mv Aptâmeros
Câncer de mama
Terapia e diagnóstico
topic Aptâmeros
Câncer de mama
Terapia e diagnóstico
Aptamer
Breast cancer
Therapy and diagnosis
Neoplasias da Mama
Diagnóstico
dc.subject.en.pt_BR.fl_str_mv Aptamer
Breast cancer
Therapy and diagnosis
dc.subject.decs.pt_BR.fl_str_mv Neoplasias da Mama
Diagnóstico
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-04-14T17:39:54Z
dc.date.available.fl_str_mv 2022-04-14T17:39:54Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA, N. C. G. et al. Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 51.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/52282
dc.identifier.doi.none.fl_str_mv 10.35259/isi.2022_52282
identifier_str_mv SILVA, N. C. G. et al. Development of a new theragnostic based on DNA aptamers against heparinase1 for the treatment of breast cancer. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 51.
10.35259/isi.2022_52282
url https://www.arca.fiocruz.br/handle/icict/52282
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/52282/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/52282/2/Anais6thISI2022_51.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
cfdefb1776468aefe9ccbc6b24234a4e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009159590772736

Registros relacionados